<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:department>Unlisted</gtr:department><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/5547DD43-641C-4DCD-80F3-C75465C11C1C"><gtr:id>5547DD43-641C-4DCD-80F3-C75465C11C1C</gtr:id><gtr:firstName>Margaret</gtr:firstName><gtr:otherNames>F</gtr:otherNames><gtr:surname>Callan</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G116%2F121"><gtr:id>ECE5112D-E3D2-4BF3-80D5-FECA6C72B8F9</gtr:id><gtr:title>An analysis of the CD4+ T cell response to Epstein-Barr virus during primary and persistent infection</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G116/121</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2006-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2001-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1598679</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Division of Immunology and Inflammation</gtr:department><gtr:description>Flu</gtr:description><gtr:id>8198C355-C772-4716-93B1-A05F5A997B17</gtr:id><gtr:impact>19342630</gtr:impact><gtr:outcomeId>51883784C02-1</gtr:outcomeId><gtr:piContribution>Provision of reagent</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Birmingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Birmingham Cancer Research UK Centre</gtr:department><gtr:description>EBV</gtr:description><gtr:id>D20CFD45-4BD9-462C-B39A-F9E5D5ED3FAB</gtr:id><gtr:impact>Publications</gtr:impact><gtr:outcomeId>54622cf41e19c9.08928546-1</gtr:outcomeId><gtr:partnerContribution>Saring of data and contribution to publications</gtr:partnerContribution><gtr:piContribution>Sharing of data and contribution to publications</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>60000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Joint Research Committee</gtr:department><gtr:description>Ph D studentship Joint Research Committee</gtr:description><gtr:end>2008-09-02</gtr:end><gtr:fundingOrg>Chelsea and Westminster Hospital NHS Foundation Trust</gtr:fundingOrg><gtr:id>F42B423C-363C-4979-B284-56311E088868</gtr:id><gtr:outcomeId>5462327874ee21.51841902</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2005-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>8D6B748D-444F-4EB7-AF52-FE26C83F8FA3</gtr:id><gtr:title>The evolution of antigen-specific CD8+ T cell responses after natural primary infection of humans with Epstein-Barr virus.</gtr:title><gtr:parentPublicationTitle>Viral immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d9b5012321ea44d3d6f7fc58cddd9d11"><gtr:id>d9b5012321ea44d3d6f7fc58cddd9d11</gtr:id><gtr:otherNames>Callan MF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2003-01-01</gtr:date><gtr:issn>0882-8245</gtr:issn><gtr:outcomeId>54622939def022.05428544</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FD129A3B-11F9-4E69-88C1-77BABD2D7BE9</gtr:id><gtr:title>Human Naive CD8 T Cells Down-Regulate Expression of the WNT Pathway Transcription Factors Lymphoid Enhancer Binding Factor 1 and Transcription Factor 7 (T Cell Factor-1) following Antigen Encounter In Vitro and In Vivo</gtr:title><gtr:parentPublicationTitle>The Journal of Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/db686f72dfc1fe57861ba687b6d5a1bb"><gtr:id>db686f72dfc1fe57861ba687b6d5a1bb</gtr:id><gtr:otherNames>Willinger T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:outcomeId>5a6f06f6b946e9.92128527</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C8DC5117-C435-4047-B067-0E0A2B24C9D8</gtr:id><gtr:title>Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections.</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dfb522a546e15789665d0484a1743ad3"><gtr:id>dfb522a546e15789665d0484a1743ad3</gtr:id><gtr:otherNames>Appay V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2002-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn><gtr:outcomeId>54622939496531.79969439</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>119A4505-CFB5-458D-95DE-283A702CAD65</gtr:id><gtr:title>Lack of Epstein-Barr virus- and HIV-specific CD27- CD8+ T cells is associated with progression to viral disease in HIV-infection.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8df06df6cdbf80b269e9948a3075e256"><gtr:id>8df06df6cdbf80b269e9948a3075e256</gtr:id><gtr:otherNames>van Baarle D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2002-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>585d5d99769508.21396065</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0C87DAA3-6CBF-4B36-817B-F0BB6A898861</gtr:id><gtr:title>The immune response to Epstein-Barr virus.</gtr:title><gtr:parentPublicationTitle>Microbes and infection</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d9b5012321ea44d3d6f7fc58cddd9d11"><gtr:id>d9b5012321ea44d3d6f7fc58cddd9d11</gtr:id><gtr:otherNames>Callan MF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>1286-4579</gtr:issn><gtr:outcomeId>5462293a847b18.11133062</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3E480B8D-0ECF-4F98-9359-BF03DA2A8636</gtr:id><gtr:title>Human CD4+ T cells are predominantly distributed among six phenotypically and functionally distinct subsets.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4cf8a6de8ba9e09e700858a71701e2e1"><gtr:id>4cf8a6de8ba9e09e700858a71701e2e1</gtr:id><gtr:otherNames>Amyes E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>5462293b27fa48.63989065</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C290B560-6B15-4BB4-92D0-4F5665DCB705</gtr:id><gtr:title>A subset of natural killer cells is greatly expanded within inflamed joints.</gtr:title><gtr:parentPublicationTitle>Arthritis and rheumatism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f30aa27945c565f9d40242f1ec7f3a0f"><gtr:id>f30aa27945c565f9d40242f1ec7f3a0f</gtr:id><gtr:otherNames>Dalbeth N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2002-01-01</gtr:date><gtr:issn>0004-3591</gtr:issn><gtr:outcomeId>546229397031b9.15332847</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>93B8FBE7-239E-4C7B-A9D6-4DEF1B4AA613</gtr:id><gtr:title>Phenotypic and functional analysis of synovial natural killer cells.</gtr:title><gtr:parentPublicationTitle>Methods in molecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f30aa27945c565f9d40242f1ec7f3a0f"><gtr:id>f30aa27945c565f9d40242f1ec7f3a0f</gtr:id><gtr:otherNames>Dalbeth N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1543-1894</gtr:issn><gtr:outcomeId>EC07EC68D91</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4AD037B2-401A-456C-8C98-28BEB90D1FE4</gtr:id><gtr:title>Epstein-Barr virus, arthritis, and the development of lymphoma in arthritis patients.</gtr:title><gtr:parentPublicationTitle>Current opinion in rheumatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d9b5012321ea44d3d6f7fc58cddd9d11"><gtr:id>d9b5012321ea44d3d6f7fc58cddd9d11</gtr:id><gtr:otherNames>Callan MF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>1040-8711</gtr:issn><gtr:outcomeId>585d5d9b990323.07516927</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5FEC4FCB-849B-4D8A-8B88-A249168FD31E</gtr:id><gtr:title>Characterization of the CD4+ T cell response to Epstein-Barr virus during primary and persistent infection.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4cf8a6de8ba9e09e700858a71701e2e1"><gtr:id>4cf8a6de8ba9e09e700858a71701e2e1</gtr:id><gtr:otherNames>Amyes E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2003-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>5462293a3bc078.23911945</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A1304B94-C98E-4E00-8FE2-72A222D9A444</gtr:id><gtr:title>Molecular Signatures Distinguish Human Central Memory from Effector Memory CD8 T Cell Subsets</gtr:title><gtr:parentPublicationTitle>The Journal of Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/db686f72dfc1fe57861ba687b6d5a1bb"><gtr:id>db686f72dfc1fe57861ba687b6d5a1bb</gtr:id><gtr:otherNames>Willinger T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:outcomeId>5a6f08615abb25.39213212</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EA9F2B6C-9731-454E-A3CA-CAC491C8FD85</gtr:id><gtr:title>Human naive CD8 T cells down-regulate expression of the WNT pathway transcription factors lymphoid enhancer binding factor 1 and transcription factor 7 (T cell factor-1) following antigen encounter in vitro and in vivo.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/db686f72dfc1fe57861ba687b6d5a1bb"><gtr:id>db686f72dfc1fe57861ba687b6d5a1bb</gtr:id><gtr:otherNames>Willinger T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>5462293b76ade9.39175614</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EF315C19-7618-4D6F-862A-AB16D906EB76</gtr:id><gtr:title>A single-chain H-2Db molecule presenting an influenza virus nucleoprotein epitope shows enhanced ability at stimulating CD8+ T cell responses in vivo.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2364e09ae5aa8bf7204f7ba871a2610a"><gtr:id>2364e09ae5aa8bf7204f7ba871a2610a</gtr:id><gtr:otherNames>Palmowski MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>1B18021412F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F5F16612-2144-4FE6-BD92-C4A3946B610C</gtr:id><gtr:title>Expression of leukocyte immunoglobulin-like receptors and natural killer receptors on virus-specific CD8+ T cells during the evolution of Epstein-Barr virus-specific immune responses in vivo.</gtr:title><gtr:parentPublicationTitle>Viral immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1c47866e33e27d02217e74f0e053ee7b"><gtr:id>1c47866e33e27d02217e74f0e053ee7b</gtr:id><gtr:otherNames>Poon K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0882-8245</gtr:issn><gtr:outcomeId>5462293b0215b4.41109398</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A949C9E0-BD90-4911-A12C-0B67D8A3935B</gtr:id><gtr:title>CD56bright NK cells are enriched at inflammatory sites and can engage with monocytes in a reciprocal program of activation.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f30aa27945c565f9d40242f1ec7f3a0f"><gtr:id>f30aa27945c565f9d40242f1ec7f3a0f</gtr:id><gtr:otherNames>Dalbeth N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>5462293aa99541.79545047</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A9705CAB-47EF-48D8-901D-B4FB644DA59A</gtr:id><gtr:title>Infectious mononucleosis and Epstein-Barr virus.</gtr:title><gtr:parentPublicationTitle>Expert reviews in molecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4176ff41e6318545c5df896199628f83"><gtr:id>4176ff41e6318545c5df896199628f83</gtr:id><gtr:otherNames>Vetsika EK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>1462-3994</gtr:issn><gtr:outcomeId>5462293ad01c76.89953075</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2CA41356-6413-4EFD-B9FB-4B250319C0D8</gtr:id><gtr:title>Mature CD8(+) T lymphocyte response to viral infection during fetal life.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/23d2c8168942b16866f1d5c1e817c38e"><gtr:id>23d2c8168942b16866f1d5c1e817c38e</gtr:id><gtr:otherNames>Marchant A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2003-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>585d61663e67a3.91943629</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E2B03508-9982-456D-A112-3E0EA5E77A2C</gtr:id><gtr:title>Human CD4+ T Cells Are Predominantly Distributed among Six Phenotypically and Functionally Distinct Subsets</gtr:title><gtr:parentPublicationTitle>The Journal of Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4cf8a6de8ba9e09e700858a71701e2e1"><gtr:id>4cf8a6de8ba9e09e700858a71701e2e1</gtr:id><gtr:otherNames>Amyes E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:outcomeId>5a6f08d99ec4d6.26583980</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BBC37313-7986-4BA2-87A6-37C002AA05CA</gtr:id><gtr:title>Arthritis and anorexia?</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f30aa27945c565f9d40242f1ec7f3a0f"><gtr:id>f30aa27945c565f9d40242f1ec7f3a0f</gtr:id><gtr:otherNames>Dalbeth N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2002-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>54622939b9b974.73568109</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>93F81320-87E3-49CF-AA51-3128B69A20CC</gtr:id><gtr:title>Clonal selection, clonal senescence, and clonal succession: the evolution of the T cell response to infection with a persistent virus.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1700a73c2a1a52c0cb9ee2512988b2b0"><gtr:id>1700a73c2a1a52c0cb9ee2512988b2b0</gtr:id><gtr:otherNames>Davenport MP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2002-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>54622939231b28.00605326</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>374A72FA-6F1D-4A76-BE5E-B7CD03EC4C61</gtr:id><gtr:title>Molecular signatures distinguish human central memory from effector memory CD8 T cell subsets.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/db686f72dfc1fe57861ba687b6d5a1bb"><gtr:id>db686f72dfc1fe57861ba687b6d5a1bb</gtr:id><gtr:otherNames>Willinger T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>5462293b513111.86136261</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CBF6A21B-4FFF-4695-A667-3E9FD50DAD25</gtr:id><gtr:title>Early acquisition of cytolytic function and transcriptional changes in a primary CD8+ T-cell response in vivo.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b0ab83ce5a962ead03102dd5b014052"><gtr:id>5b0ab83ce5a962ead03102dd5b014052</gtr:id><gtr:otherNames>Chiu C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>8A179DCA517</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G116/121</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>